Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-β1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production
- 1 December 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 82 (3) , 583-589
- https://doi.org/10.1111/j.1365-2249.1990.tb05494.x
Abstract
Summary: Recombinant human interleukin-4 (rhlL-4) and transforming growth factor-βl (TGF-β1) suppressed the induction of lymphokine-activated killer (LAK) activity induced by recombinant human interleukin-2 (rhIL-2) in peripheral blood lymphocytes. DNA synthesis and the expression of the p55 alpha chain of the IL-2 receptor (Tac antigen) were also inhibited. The inhibitory effect was greatest when these factors were added during the first 48 h of a 4-day culture, with reduced cytolytic activity against both natural killer (NK) resistant and NK-sensitive tumour cell line targets. The suppressive action of both cytokines was accompanied by a reduction in tumour necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) levels in lymphocyte culture supernatants. Recombinant human IFN-γ (rhIFN-γ). but not recombinant human TNF-α (rhTNF-α) was able to overcome the inhibitory effect of recombinant human interleukin-4(rhIL-4) on LAK induction and DNA synthesis but not Tac antigen expression. However, cytotoxicity induced by rhI FN-γ alone was also suppressed by rhIL-4 and TGF-β1, inferring that rhIFN-γ-mediated abrogation of rhlL-4 suppression was not simply a direct IL-2-indcpendent effect on cytotoxicity. In addition, rhIL-4 did not increase TGF-β production from rhIL-2-activated peripheral blood mononuclear cells, suggesting that rhIL-4 did not mediate reduction of rhIL-2 responses through the induction of TGF-β release.Keywords
This publication has 57 references indexed in Scilit:
- Functional interactions of IL2 and TNF in the differentiation of LGL into lak effectorsInternational Journal of Cancer, 1989
- The influence of interferon alpha and gamma, singly or in combination on human natural cell mediated cytotoxicityBioscience Reports, 1989
- Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon gammaImmunology Letters, 1989
- Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activityCancer Immunology, Immunotherapy, 1989
- Immunotherapy of cancer using interleukin 2: current status and future prospectsImmunology Today, 1988
- Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptorsCellular Immunology, 1988
- Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).The Journal of Experimental Medicine, 1987
- Distribution and modulation of the cellular receptor for transforming growth factor-beta.The Journal of cell biology, 1987
- IL-2- and IFNγ-enhanced natural cytotoxic activity: Analysis of the role of different lymphoid subsets and implications for activation routesCellular Immunology, 1986
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986